Evidence map›Paper›PMID 31900433›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Spitz melanoma is a distinct subset of spitzoid melanoma.

Shyam S Raghavan, Sandra Peternel, Thaddeus W Mully, Jeffrey P North, Laura B Pincus, Philip E LeBoit, Timothy H McCalmont, Boris C Bastian, Iwei Yeh

Open access · greenAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. [Spitz tumors].Pathologie (Heidelberg, Germany) · 2026
    Review
  4. Molecular pathology in the diagnosis of cutaneous melanoma.Pathologie (Heidelberg, Germany) · 2026
    Review
  5. Review
  6. Review
  7. Gene fusions in melanocytic lesions: an updated comprehensive review.Journal of pathology and translational medicine · 2026
    Article
  8. Pediatric Spitzoid Melanoma: A Case Report.Acta medica academica · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shyam S RaghavanDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3816-1542
Sandra PeternelDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-8590-0451
Thaddeus W MullyDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.
Jeffrey P NorthDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.
Laura B PincusDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.
Philip E LeBoitDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.
Timothy H McCalmontDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.
Boris C BastianDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-1836-6062
Iwei YehDepartments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, USA. Iwei.Yeh@ucsf.edu.ORCID http://orcid.org/0000-0002-3941-3561
University of California, San Francisco · USStanford University · USUniversity of Rijeka · HR

Funding

Molecular and immunologic evolution of melanomas from pre-neoplastic lesionsR35CA220481 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BASTIAN, BORIS C. · 2017 to 2023
$6.3M
NCI NIH HHS R35 CA220481
6 · The paper itself

Abstract

Melanomas that have histopathologic features that overlap with those of Spitz nevus are referred to as spitzoid melanomas. However, the diagnostic concept is used inconsistently and genomic analyses suggest it is a heterogeneous category. Spitz tumors, the spectrum of melanocytic neoplasms extending from Spitz nevi to their malignant counterpart Spitz melanoma, are defined in the 2018 WHO classification of skin tumors by the presence of specific genetic alterations, such as kinase fusions or HRAS mutations. It is unclear what fraction of "spitzoid melanomas" defined solely by their histopathologic features belong to the category of Spitz melanoma or to other melanoma subtypes. We assembled a cohort of 25 spitzoid melanomas diagnosed at a single institution over an 8-year period and performed high-coverage DNA sequencing of 480 cancer related genes. Transcriptome wide RNA sequencing was performed for select cases. Only nine cases (36%) had genetic alterations characteristic of Spitz melanoma, including HRAS mutation or fusion involving BRAF, ALK, NTRK1, or MAP3K8. The remaining cases were divided into those with an MAPK activating mutation and those without an MAPK activating mutation. Both Spitz melanoma and spitzoid melanomas in which an MAPK-activating mutation could not be identified tended to occur in younger patients on skin with little solar elastosis, infrequently harbored TERT promoter mutations, and had a lower burden of pathogenic mutations than spitzoid melanomas with non-Spitz MAPK-activating mutations. The MAPK-activating mutations identified affected non-V600 residues of BRAF as well as NRAS, MAP2K1/2, NF1, and KIT, while BRAF V600 mutations, the most common mutations in melanomas of the WHO low-CSD category, were entirely absent. While the "spitzoid melanomas" comprising our cohort were enriched for bona fide Spitz melanomas, the majority of melanomas fell outside of the genetically defined category of Spitz melanomas, indicating that histomorphology is an unreliable predictor of Spitz lineage.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkers, TumorChildChild, PreschoolDNA Mutational AnalysisFemaleHumansMaleMelanomaMiddle AgedMutationNevus, Epithelioid and Spindle CellProto-Oncogene Proteins B-rafBiomarkers, TumorBRAF protein, humanHRAS protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)

Identifiers

PMID31900433
PMCPMC7286778
OpenAlexW2997504868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.